News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Iverson Genetic Diagnostics to Sponsor the WARFARIN Study Designed to Address National Coverage and Safety Concerns of Warfarin (Coumadin(TM))


3/15/2010 1:47:49 PM

ATLANTA--(BUSINESS WIRE)--Iverson Genetic Diagnostics, Inc. today announced that they will conduct a WARFARIN clinical study to assess the efficacy of gene-based testing prior to initiating warfarin anticoagulation therapy to reduce the incidence of bleeding and thromboembolic events. The multicenter, randomized, blinded, parallel-group study is being led by Principal Investigator Dr. Elizabeth Ofili, MD, Director of Clinical Research and Associate Dean for Clinical Research at Morehouse School of Medicine.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES